Infant iron status affects iron absorption in Peruvian breastfed infants at 2 and 5 mo of age

Julia L Finkelstein1, Kimberly O O'Brien, Steven A Abrams

  • 1Division of Nutritional Sciences, Cornell University, Ithaca, NY (JLF and KOO); the USDA/Agricultural Research Service Children's Nutrition Research Center, Baylor College of Medicine, Houston, TX (SAA); and the Instituto de Investigación Nutricional, Lima, Peru (NZ).

Insights

Prenatal iron supplementation did not improve infant iron status, but fetal iron exposure enhanced early infant growth. Exclusively breastfed infants increased iron absorption when iron stores were depleted.

Area of Science:

  • Nutritional science
  • Pediatric nutrition
  • Maternal-fetal health

Background:

  • Maternal postpartum iron status and infant iron homeostasis following prenatal iron supplementation are not well understood.
  • Limited data exists on the long-term effects of prenatal iron on infant iron status and absorption.

Purpose of the Study:

  • To investigate iron absorption and growth in exclusively breastfed infants.
  • To assess the relationship between fetal iron exposure, maternal iron status, and infant iron status during early infancy.

Main Methods:

  • Longitudinal iron absorption (⁵⁸Fe) studies in 59 exclusively breastfed Peruvian infants at 2-3 and 5-6 months of age.
  • Assessment of maternal and infant iron status, including serum ferritin and transferrin receptor levels.
  • Comparison between infants born to mothers with high (≥ 5100 mg) versus low (≤ 1320 mg) supplemental prenatal iron intake.

Main Results:

  • Infant iron absorption from breast milk increased from 7.1% at 2-3 months to 13.9% at 5-6 months.
  • Maternal iron status at 2-3 months predicted infant iron deficiency at 5-6 months; 28.6% of infants had depleted iron stores by 5-6 months.
  • Prenatal iron supplementation did not affect infant iron status or breast milk nutrient concentrations, but fetal iron exposure was linked to increased infant length at both time points.

Conclusions:

  • Fetal iron exposure positively influenced early infant growth but did not significantly improve iron status or absorption.
  • Exclusively breastfed infants demonstrated an ability to upregulate iron absorption in response to depleted iron stores.
  • Further research is needed to optimize prenatal iron supplementation strategies for both maternal and infant iron status.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...